文献速递肿瘤 PET/CT

68Ga-PSMA-11 PET/CT生物分布与肝细胞癌PSMA免疫组化表达的相关性:一项前瞻性先导性单中心研究

Correlation of 68Ga-PSMA-11 PET/CT biodistribution with PSMA expression by immunohistochemistry in patients with HCC: A pilot prospective monocentric study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-09-14

该前瞻性单中心先导性研究纳入疑似肝细胞癌并接受治愈性肝切除或移植的患者,比较68Ga-PSMA-11 PET/CT半定量参数与术后病理及PSMA免疫组化表达。31例手术患者中27例(87%)PET/CT显示PSMA摄取,中位SUVmax为12.6(IQR 10.2-16.5);24例免疫组化分析中22例(91.6%)表达PSMA。高PSMA摄取与肿瘤相关血管强PSMA表达相关(p=0.028),但PET参数与Edmondson分级或血管侵犯无显著相关(p>0.05)。

要点

  • 31例手术患者中27例(87%)68Ga-PSMA-11 PET/CT显示PSMA摄取,中位SUVmax为12.6(IQR 10.2-16.5)。
  • 24例免疫组化分析中22例(91.6%)肝细胞癌表达PSMA。
  • 高PSMA摄取与肿瘤相关血管强PSMA表达相关(p=0.028)。

核心结论

  • 68Ga-PSMA-11 PET/CT对肝细胞癌具有稳健的诊断准确性,并与肿瘤血管PSMA表达相关,提示其术前分期潜在价值。

研究设计与样本

  • 前瞻性单中心先导性研究,纳入疑似肝细胞癌并接受治愈性肝切除或移植的患者,所有参与者均在3个月内完成ceMRI和68Ga-PSMA-11 PET/CT,影像结果与术后组织病理及PSMA免疫组化表达进行相关性分析。

主要发现

  • 31例手术患者中27例(87%)PET/CT显示PSMA摄取,中位SUVmax为12.6(IQR 10.2-16.5)。
  • 24例免疫组化分析中22例(91.6%)肝细胞癌表达PSMA。
  • 高PSMA摄取与肿瘤相关血管强PSMA表达相关(p=0.028)。
  • PET参数与Edmondson分级或血管侵犯等组织学特征无显著相关(p>0.05)。

临床怎么用

  • PSMA PET/CT可作为肝细胞癌术前分期的潜在影像学工具,其摄取与肿瘤血管PSMA表达相关。
  • PSMA PET/CT参数目前不能替代组织学分级或血管侵犯评估。

局限性

  • 本研究为单中心先导性研究,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Hepatocellular carcinoma (HCC) is a heterogeneous malignancy with limited diagnostic and prognostic tools beyond conventional imaging modalities such as CT and ceMRI. Prostate-specific membrane antigen (PSMA) expression, observed in the neoangiogenic endothelial cells of HCC, has emerged as a potential target. This study evaluated the correlation between PSMA biodistribution using [68Ga]Ga-PSMA-11 positron emission tomography (PSMA PET/CT) and PSMA expression by immunohistochemistry (IHC) in surgical HCC patients. Secondary aim was to assess the diagnostic performance of PSMA PET/CT in this prospective cohort. METHODS: This prospective monocentric study enrolled patients with suspected HCC undergoing curative-intent liver resection or transplantation. All participants underwent ceMRI and [68Ga]Ga-PSMA-11 PET/CT within a 3-month interval, with imaging results correlated to postoperative histopathology and IHC for PSMA expression. Semi-quantitative PET parameters were analyzed alongside tumor grade, vascular invasion, and IHC metrics. RESULTS: Eligible patients were 39, of those 31 were treated surgically. 27/31 (87%) showed PSMA uptake on PET/CT, with a median SUVmax of 12.6 (IQR10.2-16.5). According to IHC intensity analysis, PSMA was expressed in 22/24 (91.6%) of HCC. High PSMA uptake correlated with strong PSMA expression in tumor-associated vasculature (p = 0.028). No significant correlations were found between PET parameters and histological features, such as Edmondson grade or vascular invasion (p > 0.05). CONCLUSIONS: PSMA PET/CT offers robust diagnostic accuracy for HCC and correlates with vascular PSMA expression, suggesting potential utility in preoperative staging. These findings support the further exploration of PSMA imaging as a biomarker for HCC.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Vetrone L, Prosperi E, Prosperi E, et al. Correlation of 68Ga-PSMA-11 PET/CT biodistribution with PSMA expression by immunohistochemistry in patients with HCC: A pilot prospective monocentric study. Eur J Nucl Med Mol Imaging. 2026. PMID: 42734832. doi:10.1007/s00259-026-08110-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。